In silico and in vitro Characterizations of Rodent Tuber (Typhonium flagelliforme) Mutant Plant Isolates against FXR Receptor on MCF-7 Cells
Open Access
- 1 January 2024
- journal article
- research article
- Published by Japan Oil Chemists' Society in Journal of Oleo Science
- Vol. 73 (10) , 1349-1360
Abstract
Typhonium flagelliforme (T. flagelliforme) is an Indonesian rodent tuber plant traditionally used to treat cancer diseases. Although gamma-ray irradiation has been used to increase the content in the chemical compounds of the T. flagelliforme plants with anticancer activity ten times effective, the specific effect of the isolated compounds from the mutant plants has never been reported yet. The potential cytotoxic agents were characterized via nuclear magnetic resonance spectroscopy, infrared spectroscopy, and mass spectrometry as stigmasterol and 7α-hydroxyl stigmasterol; and their anticancer activity was investigated. The in silico biochemical profile of the two compounds were analyzed by molecular docking and molecular dynamics simulation to confirm its interaction with the agonist binding site of Farsenoid X receptor (FXR). Stigmasterol and 7α-hydroxyl stigmasterol can act as a competitive regulator with a high-affinity for the FXR. The results also showed that stigmasterol and 7α-hydroxyl stigmasterol were the most potential and active fraction of the T. flagelliforme mutant plant against the MCF-7 human breast cancer cell line, with IC 50 value 9.13 µM and 12.97 µM, compared with cisplastin as a control about 13.20 µM. These results demonstrate the potential of stigmasterol and 7α-hydroxyl stigmasterol in T. flagelliforme mutant plants to act towards cancer diseases.Keywords
This publication has 39 references indexed in Scilit:
- Farnesoid X receptor (FXR): Structures and ligandsComputational and Structural Biotechnology Journal, 2021
- Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptorBiochemical and Biophysical Research Communications, 2021
- Molecular Docking Study of Bioactive Compounds of Withania somnifera Extract Against Topoisomerase IV Type BProceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2019
- Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteinsApoptosis, 2017
- Ophiopogon japonicus—A phytochemical, ethnomedicinal and pharmacological reviewJournal of Ethnopharmacology, 2016
- Receptor–ligand molecular dockingBiophysical Reviews, 2013
- Evaluation of antitumor activity of stigmasterol, a constituent isolated from Bacopa monnieri Linn aerial parts against Ehrlich Ascites Carcinoma in miceOriental Pharmacy & Experimental Medicine, 2011
- Gabedit—A graphical user interface for computational chemistry softwaresJournal of Computational Chemistry, 2010
- Chemical constituents and in vitro anticancer activity of Typhonium flagelliforme (Araceae)Journal of Ethnopharmacology, 2010
- Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activationBreast Cancer Research and Treatment, 2007